8
Jul
2026

Althera Laboratories Limited

Exhibitor at CPHI South East Asia 2026 stand C08
About Us

We are a pharmaceutical company focused on developing, out-licensing, manufacturing and supplying high value branded and select complex generic medicines. We pioneer innovative value added combinations fostering benefits throughout the value chain resulting in benefits for our partners, payers, prescribers and patients particularly in heart disease, diabetes and obesity management.

  • Country/Region:
    Ireland
  • On CPHI since:
    2025
  • Certificates:
    3
  • Employees:
    100 - 249
Company types
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Out-licensing specialist
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Contact info
  • Unit 2 Holywell Commercial Centre, Swords, Dublin, Ireland
Event information
CPHI South East Asia 2026
  • 08 Jul 2026 - 10 Jul 2026
  • QSNCC, Bangkok, Thailand
  • Visit us at stand C08

Products Featured at CPHI South East Asia 2026

  • Atorvastatin+Ezetimibe Tablets

    Product Atorvastatin+Ezetimibe Tablets

    Atorvastatin+Ezetimibe Tablets 10+10mg Atorvastatin+Ezetimibe Tablets 20+10mg 
    Atorvastatin+Ezetimibe Tablets 40+10mg 
    Atorvastatin+Ezetimibe Tablets 80+10mg
  • Rosuvastatin+Fenofibrate Tablets

    Product Rosuvastatin+Fenofibrate Tablets

    Rosuvastatin+Fenofibrate Tablets 10+160mg Rosuvastatin+Fenofibrate Tablets 20+160mg
  • Sitagliptin+Dapagliflozin Tablets

    Product Sitagliptin+Dapagliflozin Tablets

    Sitagliptin+Dapagliflozin Tablets 10+100mg
    Sitagliptin+Dapagliflozin Tablets 10+50mgSitagliptin+Dapagliflozin Tablets 5+100mg
    Sitagliptin+Dapagliflozin Tablets 5+50mg